Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Telekast-D</td><td align="center">Label claim</td><td align="center">Acquired data</td><td align="center">%Recovery</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Montelukast</td><td align="center">10 mg/tab</td><td align="center">10.03 mg/tab</td><td align="center">100.30%</td></tr><tr><td align="left">Doxofylline</td><td align="center">400 mg/tab</td><td align="center">399.48 mg/tab</td><td align="center">99.87%</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Estimation of the drugs in commercial samples.

Journal of Chemistry

tab6

Table 6

Table 6: Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms 

Table 6 | Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms 